The amount of additional exchange differences recognized in profit or loss that arise from foreign currency transactions, excluding those arising on financial instruments measured at fair value through profit or loss in accordance with IFRS 9.

No definition available.

Adjustments for amortization of premium on investments to reconcile profit (loss) to net cash flow from (used in) operating activities.

No definition available.

Adjustments for the decrease (increase) in prepaid expenses and other assets to reconcile profit (loss) to net cash flow from (used in) operating activities.

No definition available.

Adjustments for depreciation and amortisation expense of right of use assets to reconcile profit (loss) to net cash flow from (used in) operating activities.

No definition available.

Adjustments for increase (decrease) in deferred offering costs to reconcile profit (loss) to net cash flow from (used in) operating activities.

No definition available.

Adjustments for increase (decrease) in research and development license liabilities to reconcile profit (loss) to net cash flow from (used in) operating activities.

No definition available.

Adjustments for increase decrease in value added tax receivable to reconcile profit (loss) to net cash flow from (used in) operating activities.

No definition available.

Represents the average credit period on domestic purchases of certain goods.

No definition available.

Amount of buy-up fee.

No definition available.

The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and current investments.

No definition available.

The amount of current license liabilities related to research and development.

No definition available.

Amount of deferred offering costs in accounts payable and accrued expenses.

No definition available.

The amount of deferred tax asset not recognized, related to accounting-to-tax differences.

No definition available.

Amount of expenses for directors board fees.

No definition available.

Tabular disclosure of interest expenses.

No definition available.

The disclosure of a maturity analysis of finance lease payments .

No definition available.

The equity impact of the foreign currency translation adjustment.

No definition available.

Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable.

No definition available.

Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.

No definition available.

Tabular disclosure of the components of cash and cash equivalents.

No definition available.

Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.

No definition available.

Percentage of vesting of award under share-based payment arrangement.

No definition available.

Percentage of vesting of remaining award under share-based payment arrangement.

No definition available.

Issue price per share of stock.

No definition available.

The fair value of stock issued in noncash financing activities.

No definition available.

Stock Issued During Period, Shares, New Issues

No definition available.

The increase (decrease) in number of shares resulting from conversion of convertible instruments.

No definition available.

Increase (decrease) in the number of shares issued through exercise of options.

No definition available.

The increase (decrease) in contract liabilities resulting from foreign currency translation difference.

No definition available.

Amount of increase (decrease) in equity resulting from equity issued in lieu of license liability.

No definition available.

The number of shares issued Increase decrease through issuance of equity shares.

No definition available.

Amount of increase (decrease) in equity resulting from equity issued in lieu of license liability.

No definition available.

The increase (decrease) in number of shares resulting from issue of equity.

No definition available.

The increase (decrease) in number of shares resulting from treasury share transactions.

No definition available.

Incremental discount rate to measure lack of marketability of options granted.

No definition available.

The amount of interest income or expense arising from deposits and borrowings, net.

No definition available.

Amount of lease commitments.

No definition available.

Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments.

No definition available.

Amount payable for license liabilities upon first and second anniversary of IPO.

No definition available.

License liabilities payables valued using the closing price of shares days prior to anniversary of IPO.

No definition available.

Amount of maximum non-refundable upfront payment receivable.

No definition available.

Maximum additional tumor targets number.

No definition available.

Amount of maximum reimbursement entitles to received.

No definition available.

The amount of non-current license liabilities related to research and development.

No definition available.

Number of remaining tranches.

No definition available.

Number of tranches.

No definition available.

Represents about exercisable term of options.

No definition available.

The amount of non-current assets that the entity does not separately disclose in the same statement or note and security deposits.

No definition available.

Amount of cash outflow for payment of license liability.

No definition available.

Percentage of increase (decrease) in certain future milestones in the event we exercise the buy-up option and pay the buy-up fee.

No definition available.

The percent of increase (decrease) in interest rate and currency rate that would have material effect of fair market value of portfolio.

No definition available.

Percentage of amount payable in lieu of equity license liability.

No definition available.

Proceeds from issuance of preferred stock net of cost of repurchase of stock.

No definition available.

Proceeds from issuance of preferred stock net of issuance costs.

No definition available.

Proportion of equity interest held.

No definition available.

Amount of expenses for related party consultancy fees.

No definition available.

Development milestones payment received under research and license agreement.

No definition available.

Non-refundable upfront payment received under research and license agreement.

No definition available.

Years of sale for royalties payable under research and license agreement.

No definition available.

A component of equity representing the equity-settled employee benefits reserve.

No definition available.

The increase (decrease) in right-of-use assets resulting from net exchange differences arising on the translation of the financial statements from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity.

No definition available.

The tabular disclosure of major shareholders on a non-diluted basis.

No definition available.

The total percentage of vesting of award under share-based payment arrangement.

No definition available.

The weighted average remaining contractual life of share options, granted.

No definition available.

Shareholding percentage.

No definition available.

Number of shares issued in lieu of license liability.

No definition available.

Percentage of shares issued in lieu of license liability of the payable per the agreement.

No definition available.

Amount of stock split.

No definition available.

The amount of shares to be repurchased by an entity's Board of Directors under a stock repurchase plan.

No definition available.

The number of shares to be repurchased by an entity's Board of Directors under a stock repurchase plan.

No definition available.

Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.

No definition available.

Amount of taxable income (expenses) declared in the tax returns files per innovation box tax scheme.

No definition available.

Term of agreement over which upfront payment received are recognized on a straight-line basis.

No definition available.

Amount of expenses for underwriters discount and commission.

No definition available.

Amount of lessee's undiscounted obligation for lease payments.

No definition available.

The amount of unused tax losses for IP development cost activated per innovation box tax scheme available to be offset against future income.

No definition available.

The Innovation Box tax rate, a corporate income tax incentive introduced in Dutch tax law.

No definition available.

No definition available.

No definition available.

Tabular disclosure of general and administrative expenses.

No definition available.

The amount of facilities and other research and development expenses directly attributable to research or development activities, recognised in profit or loss.

No definition available.

The amount of personnel-related expenses directly attributable to research or development activities, recognised in profit or loss.

No definition available.

The amount of pre-clinical and clinical trial expenses directly attributable to research or development activities, recognised in profit or loss.

No definition available.

The amount of research and development activities expenses directly attributable to research or development activities, recognised in profit or loss.

No definition available.

The amount of share-based compensation expense directly attributable to research or development activities, recognised in profit or loss.

No definition available.

No definition available.

The amount of license expenses directly attributable to research or development activities, recognised in profit or loss.

No definition available.

No definition available.

Tabular disclosure of accrued expenses and other current liabilities.

No definition available.

n/a.

No definition available.

Tabular disclosure of tax loss carryforward expiry disclosure.

No definition available.

Tabular disclosure of the reconciliation of income tax expense at statutory tax rate and the income expenses as reported in the consolidated statement of loss and other comprehensive income.

No definition available.

Tabular disclosure of unrecognized deferred tax assets.

No definition available.

n/a.

No definition available.

The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to change in deferred tax rate.

No definition available.

The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to previously unrecognized tax losses now recouped to reduce current tax expenses.

No definition available.

The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to unrecognized deferred tax for losses and temporary differences.

No definition available.

No definition available.

Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

No definition available.

Carrying value as of the balance sheet date of obligations incurred through that date and payable for research and development external project costs.

No definition available.